Affiliate Disclosure and Commercial Relationships

The initial provider pool is drawn from Katalys because it is a platform The Compound knows and may use for future partnerships. Official offer and policy verification then determines what we can actually publish. This creates a limited starting set; it is not a claim to cover the whole market or every affordable option.

A provider can appear before a partnership exists. Audited facts retain direct official source links. PeterMD has separate approved destinations for sermorelin, NAD+ injections, NAD+ capsules and its general longevity catalog; the general destination is reserved for broad placements. Embody has separate approved destinations for NAD+ and sermorelin. Luvo Health has product-specific partner links for sermorelin, NAD+ injections and NAD+ liquid drops, plus a broad program destination used only for general placements. Pallas currently uses direct official links. Wellorithm has separate NAD+ and sermorelin partner destinations. Sprout has an NAD+ link; System Labs and RNK Health have separate NAD+ and sermorelin links. RNK also has a general homepage destination used only for broad catalog mentions; its duplicate default NAD+ landing is not used. HealthRX has a full NAD+ and sermorelin review, and the TMates NAD+ review has its own labeled partner link. DudeMeds remains covered as an informational review; no current public NAD+ purchase offer was established from its anti-aging page and catalog. RxSpan MD has an approved broad longevity-catalog destination; MyDrHank has separate NAD+ and sermorelin destinations behind a location check. Commercial links do not change the audited price table or editorial findings. Inspect the current plan set.

Yes. PeterMD, Embody, Luvo Health, Wellorithm NAD+ and sermorelin, Sprout NAD+, System Labs NAD+ and sermorelin, RNK Health NAD+ and sermorelin, HealthRX, TMates, RxSpan MD, Live Vital and MyDrHank currently have labeled partner links on this site. A valid tracking link is not proof that every product earns commission. GHK-Cu and glutathione destinations are not in use while their product fit or terms remain unresolved. If product eligibility or other partnerships change, we update the affected disclosures. We do not assume that another Compound website's approval applies here.

Live Vital has an approved NAD+ product destination. Eden has a full longevity review but no matching NAD+ or sermorelin affiliate landing: its available program destination concerns GLP-1 care. We therefore publish Eden evidence citations without commercial buttons. Approval for one treatment does not establish an appropriate link for another.

RxSpan MD buttons are labeled as catalog links because the approved destination contains multiple products. Its NAD+ formats and sermorelin ODT remain distinct. MyDrHank has separate approved NAD+ and sermorelin destinations. Its partner offer excludes Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia, so a first-party location check keeps ordinary provider links for excluded or unspecified locations. The choice is not saved or sent to analytics.

Read the RxSpan MD review or read the MyDrHank review. A provider review can appear in the directory even when its complete comparable payment schedule is unknown.

Our newer source-backed NAD+ and sermorelin reviews, and the NAD+ and sermorelin cost and provider guides, link to product-specific Everflow offers for Enhanced, Lttl and Taurus. On the guides they sit in a labeled partner section, outside the audited price board. Network approval alone does not add a provider to that board or establish clinical quality. Their product, payment and evidence gaps remain visible. BMI MD partner offers exclude California and South Carolina. Its product buttons first open a location check: another US state or Washington, DC enables the matching partner offer; excluded or unspecified locations retain an ordinary provider link. The location answer is not saved or sent to analytics. Glutathione and MIC+B12 inventory remains outside the NAD+ and sermorelin shortlist.

Our privacy policy explains optional referral matching and how to change your analytics choice.

No. Commission, affiliate status and payout size do not determine objective price order or an editorial score. Recommendations must have a defensible reader-specific reason and include material limitations. Corrections apply even when they make a partner look less attractive. Read the comparison rules.